Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine

Author： Giancarlo Gina M. Venkatakrishnan Karthik Granda Brian W. von Moltke Lisa L. Greenblatt David J.

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.57, Iss.1, 2001-04, pp. : 31-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Hydroxylation of R (+)- and S (−)-Omeprazole after Racemic Dosing are Different among the CYP2C19 Genotypes

By Shiohira Hideo

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2310-2316

Springer Publishing Company

Access to resources Recommend Favorite

Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro

By Pan Yan Tiong Kai Abd-Rashid Badrul Ismail Zakiah Ismail Rusli Mak Joon Ong Chin

Journal of Natural Medicines, Vol. 68, Iss. 2, 2014-04 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome P450 2C19 (CYP2C19) genotype appears to affect the efficacy of omeprazole

Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Identification of cytochromes P₄₅₀ 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro

By Ufer Mike Svensson Jan Krausz Kristopher Gelboin Harry Rane Anders Tybring Gunnel

European Journal of Clinical Pharmacology, Vol. 60, Iss. 3, 2004-05 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs

By Sugimoto Katsuyoshi

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 583-587

Springer Publishing Company

Access to resources Recommend Favorite